Muscular Dystrophy: Inhibition of Degeneration in Vivo with Protease Inhibitors

Overview

Journal Science

Specialty Science

Date 1978 Apr 7

PMID 635570

Citations 19

Authors

A Stracher

E B McGowan

S A SHAFIQ

Affiliations

Soon will be listed here.

Abstract

The protease inhibitors leupeptin and pepstatin were used in vivo in genetically dystrophic chickens to determine their effects on the histological and biochemical changes observed in this disease. These compounds appear to delay the degeneration of muscle tissue which is characteristic of this disorder and thus may have potential therapeutic value in the treatment of muscular dystrophy.

Citing Articles

Inhibition of proteolysis by a cyclooxygenase inhibitor, indomethacin.

Banik N, Matzelle D, Terry E, Hogan E Neurochem Res. 2000; 25(11):1509-15.

PMID: 11071371 DOI: 10.1023/a:1007684311023.

Interacting effects of Ca2+ and hypoxia in the induction of sarcolemmal damage in mouse diaphragm in vitro.

Bannister N, Publicover S Acta Neuropathol. 1995; 90(4):411-4.

PMID: 8546032 DOI: 10.1007/BF00315015.

Immunolocalization of ubiquitin in degenerating insect flight muscle.

Davis W, Jacoby B, GOODMAN D Histochem J. 1994; 26(4):298-305.

PMID: 8040003 DOI: 10.1007/BF00157762.

Effects of chymostatin and other proteinase inhibitors on protein breakdown and proteolytic activities in muscle.

Libby P, GOLDBERG A Biochem J. 1980; 188(1):213-20.

PMID: 7406880 PMC: 1162558. DOI: 10.1042/bj1880213.

Myofibrillar protein degradation in the chicken. 3-Methylhistidine release in vivo and in vitro in normal and genetically muscular-dystrophic chickens.

Hillgartner F, Williams A, Flanders J, Morin D, Hansen R Biochem J. 1981; 196(2):591-601.

PMID: 7316997 PMC: 1163033. DOI: 10.1042/bj1960591.